Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(D'Amato Mauro) "

Sökning: WFRF:(D'Amato Mauro)

  • Resultat 1-10 av 78
  • [1]234567...8Nästa
Sortera/gruppera träfflistan
  • Beyder, Arthur, et al. (författare)
  • Loss-of-Function of the Voltage-Gated Sodium Channel Na(V)1.5 (Channelopathies) in Patients With Irritable Bowel Syndrome
  • 2014
  • Ingår i: Gastroenterology. - Elsevier. - 1528-0012. ; 146:7, s. 1659-1668
  • Tidskriftsartikel (refereegranskat)abstract
    • BACKGROUND & AIMS: SCN5A encodes the a-subunit of the voltage-gated sodium channel Na(V)1.5. Many patients with cardiac arrhythmias caused by mutations in SCN5A also have symptoms of irritable bowel syndrome (IBS). We investigated whether patients with IBS have SCN5A variants that affect the function of Na(V)1.5. METHODS: We performed genotype analysis of SCN5A in 584 persons with IBS and 1380 without IBS (controls). Mutant forms of SCN5A were expressed in human embryonic kidney-293 cells, and functions were assessed by voltage clamp analysis. A genome-wide association study was analyzed for an association signal for the SCN5A gene, and replicated in 1745 patients in 4 independent cohorts of IBS patients and controls. RESULTS: Missense mutations were found in SCN5A in 13 of 584 patients (2.2%, probands). Diarrhea-predominant IBS was the most prevalent form of IBS in the overall study population (25%). However, a greater percentage of individuals with SCN5A mutations had constipation-predominant IBS (31%) than diarrhea-predominant IBS (10%; P < .05). Electrophysiologic analysis showed that 10 of 13 detected mutations disrupted Na(V)1.5 function (9 loss-of-function and 1 gain-of-function function). The p. A997T-Na(V)1.5 had the greatest effect in reducing Na(V)1.5 function. Incubation of cells that expressed this variant with mexiletine restored their sodium current and administration of mexiletine to 1 carrier of this mutation (who had constipation-predominant IBS) normalized their bowel habits. In the genome-wide association study and 4 replicated studies, the SCN5A locus was strongly associated with IBS. CONCLUSIONS: About 2% of patients with IBS carry mutations in SCN5A. Most of these are loss-of-function mutations that disrupt Na(V)1.5 channel function. These findings provide a new pathogenic mechanism for IBS and possible treatment options.
  • Cordeddu, Lina, et al. (författare)
  • Severe gastrointestinal dysmotility developed after treatment with gonadotropin-releasing hormone analogs
  • 2015
  • Ingår i: Scandinavian Journal of Gastroenterology. - Taylor & Francis. - 1502-7708. ; 50:3, s. 291-299
  • Tidskriftsartikel (refereegranskat)abstract
    • Background. Sporadic cases of abdominal pain and dysmotility has been described after treatment with gonadotropin-releasing hormone (GnRH) analogs. The aim of the present study was to scrutinize for patients with severe gastrointestinal complaints after treatment with GnRH analogs, to describe the expression of antibodies against progonadoliberin-2, GnRH1, GnRH receptor (GnRHR), luteinizing hormone (LH), and LH receptor in serum in these patients, and to search for possible triggers and genetic factors behind the development of this dysmotility. Methods. Patients suffering from prolonged gastrointestinal complaints after treatment with GnRH analogs at the Department of Gastroenterology, Skane University Hospital, were included. GnRHR and LH receptor (LHCGR) genes were exome-sequenced. Serum was analyzed by enzyme-linked immune sorbent assays for the presence of antibodies. Healthy blood donors and women treated with GnRH analogs because of in vitro fertilization (IVF) were used as controls. Results. Seven patients with severe gastrointestinal complaints after GnRH treatment were identified, of whom six suffered from endometriosis. Several variants were found within the 11 exons of LHCGR. The minor allele G, at the single nucleotide polymorphism rs6755901, was detected in homozygosity in two patients (28.5%) who had developed chronic intestinal pseudo-obstruction and in 5.5% of the IVF controls. Three patients expressed IgM antibodies against progonadoliberin-2 and three against GnRH1 (42.9%) when cut off was set to a titer >97.5th percentile in blood donors. Conclusion. A high prevalence of endometriosis, polymorphism in the LHCGR and GnRH1 and progonadoliberin-2 antibodies in serum was found among the patients with severe dysmotility after treatment with GnRH analogs.
  • Ek, Weronica E., et al. (författare)
  • Exploring the genetics of irritable bowel syndrome: a GWA study in the general population and replication in multinational case-control cohorts
  • 2015
  • Ingår i: Gut. - 1468-3288. ; 64:11, s. 1774-1782
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective IBS shows genetic predisposition, but adequately powered gene-hunting efforts have been scarce so far. We sought to identify true IBS genetic risk factors by means of genome-wide association (GWA) and independent replication studies. Design We conducted a GWA study (GWAS) of IBS in a general population sample of 11 326 Swedish twins. IBS cases (N=534) and asymptomatic controls (N=4932) were identified based on questionnaire data. Suggestive association signals were followed-up in 3511 individuals from six case-control cohorts. We sought genotype-gene expression correlations through single nucleotide polymorphism (SNP)-expression quantitative trait loci interactions testing, and performed in silico prediction of gene function. We compared candidate gene expression by real-time qPCR in rectal mucosal biopsies of patients with IBS and controls. Results One locus at 7p22.1, which includes the genes KDELR2 (KDEL endoplasmic reticulum protein retention receptor 2) and GRID2IP (glutamate receptor, ionotropic, delta 2 (Grid2) interacting protein), showed consistent IBS risk effects in the index GWAS and all replication cohorts and reached p=9.31 x 10(-6) in a meta-analysis of all datasets. Several SNPs in this region are associated with cis effects on KDELR2 expression, and a trend for increased mucosal KDLER2 mRNA expression was observed in IBS cases compared with controls. Conclusions Our results demonstrate that general population-based studies combined with analyses of patient cohorts provide good opportunities for gene discovery in IBS. The 7p22.1 and other risk signals detected in this study constitute a good starting platform for hypothesis testing in future functional investigations.
  • Sand, Elin, et al. (författare)
  • Expression and distribution of GnRH, LH, and FSH and their receptors in gastrointestinal tract of man and rat.
  • 2013
  • Ingår i: Regulatory Peptides. - Elsevier. - 1873-1686. ; 187, s. 24-28
  • Tidskriftsartikel (refereegranskat)abstract
    • Gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), and follicle-stimulating hormone (FSH) regulate the reproductive axis. Their analogs have been found to influence gastrointestinal activity and enteric neuronal survival. The aims of the study were to investigate expression and cellular distribution of GnRH, LH, and FSH and their receptors in human and rat gastrointestinal tract.
  • Westerlind, Helga, et al. (författare)
  • Dense genotyping of immune-related loci identifies HLA variants associated with increased risk of collagenous colitis.
  • 2017
  • Ingår i: Gut. - BMJ Publishing Group. - 1468-3288. ; 66, s. 421-428
  • Tidskriftsartikel (refereegranskat)abstract
    • Collagenous colitis (CC) is a major cause of chronic non-bloody diarrhoea, particularly in the elderly female population. The aetiology of CC is unknown, and still poor is the understanding of its pathogenesis. This possibly involves dysregulated inflammation and immune-mediated reactions in genetically predisposed individuals, but the contribution of genetic factors to CC is underinvestigated. We systematically tested immune-related genes known to impact the risk of several autoimmune diseases for their potential CC-predisposing role.
  • Wouters, Mira M., et al. (författare)
  • Genetic variants in CDC42 and NXPH1 as susceptibility factors for constipation and diarrhoea predominant irritable bowel syndrome
  • 2014
  • Ingår i: Gut. - BMJ Publishing Group. - 1468-3288. ; 63:7, s. 1103-1111
  • Tidskriftsartikel (refereegranskat)abstract
    • Objective The complex genetic aetiology underlying irritable bowel syndrome (IBS) needs to be assessed in large-scale genetic studies. Two independent IBS cohorts were genotyped to assess whether genetic variability in immune, neuronal and barrier integrity genes is associated with IBS. Design 384 single nucleotide polymorphisms (SNPs) covering 270 genes were genotyped in an exploratory cohort (935 IBS patients, 639 controls). 33 SNPs with P-uncorrected<0.05 were validated in an independent set of 497 patients and 887 controls. Genotype distributions of single SNPs were assessed using an additive genetic model in IBS and clinical subtypes, IBS-C and IBS-D, both in individual and combined cohorts. Trait anxiety (N=614 patients, 533 controls), lifetime depression (N=654 patients, 533 controls) and mRNA expression in rectal biopsies (N=22 patients, 29 controls) were correlated with SNP genotypes. Results Two SNPs associated independently in the exploratory and validation cohort: rs17837965-CDC42 with IBS-C (ORexploratory=1.59 (1.05 to 1.76); ORvalidation=1.76 (1.03 to 3.01)) and rs2349775-NXPH1 with IBS-D (ORexploratory=1.28 (1.06 to 1.56); ORvalidation=1.42 (1.08 to 1.88)). When combining both cohorts, the association of rs2349775 withstood post hoc correction for multiple testing in the IBS-D subgroup. Additionally, three SNPs in immune-related genes (rs1464510-LPP, rs1881457-IL13, rs2104286-IL2RA), one SNP in a neuronal gene (rs2349775-NXPH1) and two SNPs in epithelial genes (rs245051-SLC26A2, rs17837965-CDC42) were weakly associated with total-IBS (P-uncorrected<0.05). At the functional level, rs1881457 increased IL13 mRNA levels, whereas anxiety and depression scores did not correlate with rs2349775-NXPH1. Conclusions Rs2349775 (NXPH1) and rs17837965 (CDC42) were associated with IBS-D and IBS-C, respectively, in two independent cohorts. Further studies are warranted to validate our findings and to determine the mechanisms underlying IBS pathophysiology.
  • Zucchelli, Marco, et al. (författare)
  • Association of TNFSF15 polymorphism with irritable bowel syndrome.
  • 2011
  • Ingår i: Gut. - 1468-3288. ; 60:12, s. 1671-7
  • Tidskriftsartikel (refereegranskat)abstract
    • Background Irritable bowel syndrome (IBS) is the most common gastrointestinal disorder, affecting more than 10% of the general population worldwide. Although a genetic component is suspected, unambiguous susceptibility genes have so far not been identified. This study tested the hypothesis that genes contributing to epithelial barrier integrity, control of mucosal immune responses and interactions with bacteria in the gut are associated with IBS. Methods Single nucleotide polymorphisms (SNPs) corresponding to top signals of association with Crohn's disease at 30 known susceptibility loci were tested for their effect on IBS risk in 1992 individuals from two independent case-control cohorts from Sweden and the USA. Association tests included a conservative Bonferroni correction for multiple comparisons, and were also performed on specific subgroups of patients characterised by constipation (IBS-C), diarrhoea (IBS-D) or alternating constipation and diarrhoea (IBS-A). Results The Crohn's disease risk allele rs4263839 G in the TNFSF15 gene was significantly associated with an increased risk of both IBS (p=2.2 x 10(-5); OR 1.37) and more pronouncedly, IBS-C (p=8.7 x 10(-7); OR 1.79) in the entire sample. Similar associations and risk effects of the same magnitude were observed in the two cohorts analysed separately. A correlation between rs4263839 genotype and TNFSF15 mRNA expression was detected both in peripheral blood and in rectal mucosal biopsies from healthy individuals (combined p=0.0033). Conclusions TNFSF15 is a susceptibility gene for IBS and IBS constipation. As TL1A, the protein encoded by TNFSF15, contributes to the modulation of inflammatory responses, the results support a role of immune activation in IBS.
  • Anedda, Francesca, et al. (författare)
  • Multiple polymorphisms affect expression and function of the neuropeptide S receptor (NPSR1)
  • 2011
  • Ingår i: PLoS ONE. - 1932-6203 .- 1932-6203. ; 6:12, s. e29523
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background: neuropeptide S (NPS) and its receptor NPSR1 act along the hypothalamic-pituitary-adrenal axis to modulate anxiety, fear responses, nociception and inflammation. The importance of the NPS-NPSR1 signaling pathway is highlighted by the observation that, in humans, NPSR1 polymorphism associates with asthma, inflammatory bowel disease, rheumatoid arthritis, panic disorders, and intermediate phenotypes of functional gastrointestinal disorders. Because of the genetic complexity at the NPSR1 locus, however, true causative variations remain to be identified, together with their specific effects on receptor expression or function. To gain insight into the mechanisms leading to NPSR1 disease-predisposing effects, we performed a thorough functional characterization of all NPSR1 promoter and coding SNPs commonly occurring in Caucasians (minor allele frequency &gt;0.02). Principal Findings: we identified one promoter SNP (rs2530547 [-103]) that significantly affects luciferase expression in gene reporter assays and NPSR1 mRNA levels in human leukocytes. We also detected quantitative differences in NPS-induced genome-wide transcriptional profiles and CRE-dependent luciferase activities associated with three NPSR1 non-synonymous SNPs (rs324981 [Ile107Asn], rs34705969 [Cys197Phe], rs727162 [Arg241Ser]), with a coding variant exhibiting a loss-of-function phenotype (197Phe). Potential mechanistic explanations were sought with molecular modelling and bioinformatics, and a pilot study of 2230 IBD cases and controls provided initial support to the hypothesis that different cis-combinations of these functional SNPs variably affect disease risk. Significance: these findings represent a first step to decipher NPSR1 locus complexity and its impact on several human conditions NPS antagonists have been recently described, and our results are of potential pharmacogenetic relevance.</p>
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 78
  • [1]234567...8Nästa
fritt online (9)
Typ av publikation
tidskriftsartikel (75)
forskningsöversikt (2)
annan publikation (1)
Typ av innehåll
refereegranskat (66)
övrigt vetenskapligt (15)
D'Amato, Mauro (78)
Agréus, Lars (38)
Ohlsson, Bodil (37)
Lindberg, Greger (32)
Dlugosz, Aldona (32)
Karling, Pontus, (30)
visa fler...
Simren, Magnus (29)
Schmidt, Peter T., (29)
Andreasson, Anna, (28)
Bonfiglio, Ferdinand ... (24)
Bresso, Francesca (23)
Walter, Susanna, (23)
Franke, Andre (22)
Assadi, Ghazaleh, (22)
Camilleri, Michael (22)
Halfvarson, Jonas (18)
Bellini, Massimo (18)
Barbara, Giovanni (18)
Halfvarson, Jonas, 1 ... (17)
Talley, Nicholas J., (17)
Hadizadeh, Fatemeh, (17)
Wouters, Mira M., (17)
Boeckxstaens, Guy, (16)
Törkvist, Leif (14)
Zheng, Tenghao, (14)
Daly, Mark J. (13)
Zucchelli, Marco (13)
Nardone, Gerardo (13)
Cuomo, Rosario (13)
Usai-Satta, Paolo (13)
Galeazzi, Francesca (13)
Neri, Matteo (13)
Portincasa, Piero (13)
Duerr, Richard H., (12)
Ek, Weronica E. (12)
Bujanda, Luis, (12)
Latiano, Anna, (10)
Chang, Lin, (10)
Engstrand, Lars, (9)
D'Amato, M, (9)
Ohlsson, B (9)
Silverberg, Mark S (9)
Padyukov, Leonid, (9)
Torkvist, Leif (9)
Annese, Vito, (9)
Simrén, M (8)
Weersma, Rinse K (8)
Vermeire, Severine, (8)
Mayer, Emeran A., (8)
Gazouli, Maria (8)
visa färre...
Örebro universitet (23)
Lunds universitet (13)
Karolinska Institutet (13)
Stockholms universitet (12)
Linköpings universitet (10)
Uppsala universitet (9)
visa fler...
Göteborgs universitet (7)
Umeå universitet (7)
Kungliga Tekniska Högskolan (4)
visa färre...
Engelska (77)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (74)
Naturvetenskap (5)
Samhällsvetenskap (1)


pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy